Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy.

Congenital muscular dystrophy is a distinct group of diseases presenting with weakness in infancy or childhood and no current therapy. One form, MDC1A, is the result of laminin alpha-2 deficiency and results in significant weakness, respiratory insufficiency and early death. Modification of apoptosi...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Qing Yu, Arpana Sali, Jack Van der Meulen, Brittany K Creeden, Heather Gordish-Dressman, Anne Rutkowski, Sree Rayavarapu, Kitipong Uaesoontrachoon, Tony Huynh, Kanneboyina Nagaraju, Christopher F Spurney
Format:	Artigo
Jezik:	Inglês
Izdano:	Public Library of Science (PLoS) 2013-01-01
Serija:	PLoS ONE
Online dostop:	http://europepmc.org/articles/PMC3675144?pdf=render
Oznake:	Označite Brez oznak, prvi označite!